Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
Misonidazole (MISO) has been shown to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in a number of different animal tumor systems. The authors have investigated the response to therapy of the various subpopulations of cells comprising the KHT sarcoma, to determine whether chemopotentiation occurred as a preferential enhancement of killing in one subpopulation of cells. Twenty-four hr after drug treatment, cells dissociated from solid tumors were separated into homogeneous populations based on cell size by the technique of centrifugal elutriation. Clonogenic cell survival was measured for each elutriated fraction. In vivo treatment with MISO produced no measurable cell-kill across the cell cycle. Those cells in late G/sub 1/ and S phase 24 hr after treatment were most sensitive to CCNU alone. The enhancement of CCNU cytotoxicity by MISO occurred primarily in the early G/sub 1/ and S fractions. These data suggest that chemopotentiation does not occur equally in all tumor cell subpopulations and that some specificity of enhanced cell killing exists.
Research Organization:
Univ. of Rochester Cancer Center, NY
OSTI ID:
6166996
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:9; ISSN IOBPD
Country of Publication:
United States
Language:
English